Navigation Links
Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung
Date:7/13/2014

ittel (CHMP) erteilte die Europäische Kommission (EK) Astellas und Medivation im Juni 2013 die Marktzulassung für XTANDI (Enzalutamid) zur Behandlung von männlichen mCRPC-Patienten (kastrationsresistenter metastasierender Prostatakrebs), deren Erkrankung während bzw. nach der Docetaxel-Therapie weiter fortschreitet. Um die Behandlung von chemotherapienaivem metastasierendem Prostatakrebs im Marktzulassungsantrag von XTANDI zu berücksichtigen, wurde im April 2014 eine Änderung vorgelegt. Darüber hinaus wurde der Entwicklungsfortschritt bei klinischen Studien zur Behandlung von Brustkrebs thematisiert. 
  • Die Phase-2-Ergebnisse von Roxadustat (ASP1517/FG-4592) haben gezeigt, dass das Präparat die Behandlung und Pflege einer Anämie bei Dialyse- und Nicht-Dialyse-Patienten mit chronischem Nierenleiden wirksam unterstützt. Sechs in Kooperation mit FibroGen durchgeführte Phase-3-Studien werden sich im Zusammenhang mit Zulassungsanträgen für Dialyse- und Nicht-Dialyse-Indikationen in Europa als hilfreich erweisen.  
  • Ein globales Phase-3-Programm zwecks Bewertung der Wirksamkeit und Sicherheit einer zeitgleichen Anwendung von Solifenacin (als VESICARE™ vermarktet) und Mirabegron (als BETMIGA™ vermarktet) zur Behandlung von Blasenhyperaktivität hat bereits begonnen.
  • In den USA hat Astellas die Zulassung von Isavuconazol als neues Medikament zur Behandlung von invasiver Aspergillose und invasiver Mukormykose beantragt.
  • In Japan bereitet sich das Unternehmen derzeit auf den Beginn des Phase-3-Programms von ASP015K vor: Der JAK-Inhibitor zur Behandlung von Gelenkrheumatismus hat kürzlich Phase-2b-Studien erfolgreich durchlaufen. Die Wirksamkeits- und Sicherheitsergebnisse aus Studien mit und ohne Methotrexat bieten eine solide Datengrundlage, die den Übergang zu diesem klinischen Phase-3-Progr
    '/>"/>

  • SOURCE Astellas Pharma Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. First sales of DIFICLIR™ by Astellas Pharma Europe triggers 10 Million Euro Milestone Payment to Optimer Pharmaceuticals
    2. Astellas and Fujita Health University Discover Neuronal Maturation Deficits in Patients Suffering from Schizophrenia and Bipolar Disorder
    3. Astellas to Close Urogenix, North Carolina-based Urology Research Facility
    4. Personal Connections Drive Employee Participation For Changing Tomorrow Day at Astellas
    5. Astellas Announces Acceptance of U.S. New Drug Application for Tacrolimus Extended Release Capsules
    6. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
    7. Astellas Highlights Progress to Advance Care of Patients with Genitourinary Cancers at ASCO-GU Annual Meeting
    8. Astellas to Drive PGA TOURs New Womens Initiative
    9. PGA TOUR Celebrates Official Launch of the Astellas Presents Executive Womens Day Program
    10. Astellas and Ambit to End Collaboration for Joint Development and Commercialization of FLT3 Kinase Inhibitors
    11. Astellas Pharma Inc.: New Hire Reinforces Global Compliance Structure
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/17/2015)... Apr. 16, 2015 Research and Markets ... "Corporate Reputation of Pharma in 2014 - a ... report to their offering. This independent study, ... patient groups with an interest in diabetes on the ... the pharma industry as a whole) in 2014. The ...
    (Date:4/17/2015)... , Apr. 16, 2015 Research and Markets ... the "Corporate Reputation of Pharma in 2014 - ... Edition" report to their offering. For ... opinions on the corporate reputation of the pharmaceutical industry ... health with the views of patient organisations representing all ...
    (Date:4/17/2015)... TAIPEI , April 17, 2015 TWi ... fully-owned subsidiary, TWi Pharmaceuticals USA , ... in the United States.  It has been in close ... wholesalers and expects to have its own label specialty ... soon in the U.S. pharma market. According ...
    Breaking Medicine Technology:Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 4Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 5Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 2Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 3
    ... Genomic Health , Inc. (Nasdaq: GHDX ... Financial Officer, will present at the 31st Annual Canaccord ... 2011 at 11:30 a.m. Eastern Time (ET).   ... of the presentation, visit the Investor Relations section of ...
    ... 2011 It,s back-to-school season and for many families, ... To view the multimedia assets associated with ... (Photo: http://photos.prnewswire.com/prnh/20110804/MM45457 ) Each ... U.S. are infested with this common, six-legged critter that ...
    Cached Medicine Technology:Genomic Health to Present at the Canaccord Genuity Growth Conference 2Head Lice Returns to School: Five Tips to Avoid Panic and Worry 2
    (Date:4/19/2015)... 2015 HealthPostures, LLC , a ... will exhibit it’s pioneering ergonomics products at the Wisconsin ... Safety Council Professional Development Conference and Expo . The ... are used in volume by call centers, educational organizations, ... to clamp to a desk, the TaskMate Go 6350 ...
    (Date:4/18/2015)... April 18, 2015 Carinsurancesavings.biz has released ... plans are cheaper during Spring. , Spring ... insurance plan. Drivers should make sure they compare the ... vehicles. Clients can learn more about Spring car insurance ... , Auto insurance quotes are becoming more and more ...
    (Date:4/18/2015)... Insuranceautoquote.info has released a new blog post explaining how ... , Clients can review important auto insurance quotes online, ... important advantages for clients who need affordable financial security ... have coverage for their vehicles can purchase a policy ... Many agencies offer important discounts and drivers can learn ...
    (Date:4/18/2015)... the past few weeks, TheBeautyPlace.com has been undergoing maintenance ... run maintenance on our shipping facilities to update software ... Director. "It disrupted our regular shipping schedule but we ... track after having completed the maintenance." , Now, TheBeautyPlace.com ... has not allowed some calls to come in through ...
    (Date:4/18/2015)... PHOENIX, ARIZONA – In March, Mark Ona, Territory ... destruction professionals across the United States, earned the professional ... display “CSDS” as a professional title with his name. ... of Information Destruction 2015 Annual Conference began - one ... 20 people who took the exam, Ona was amongst ...
    Breaking Medicine News(10 mins):Health News:HealthPostures' TaskMate Products to be Exhibited at the Wisconsin and Iowa-Illinois Safety Conferences 2Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2Health News:TheBeautyPlace.com Temporary Number Available 2
    ... generic drug approval process; provide more options ... for consumers, health professionals, WASHINGTON, ... a program aimed at increasing the number and,variety of generic ... generally cost less than their brand-name,counterparts and competition among generics ...
    ... canola,oil for common dietary fats in the U.S. ... and plant omega-3 fats,noted a modeling study published ... the American Dietetic Association (JADA). The study examined ... oils and canola oil-based,margarine for other margarines and ...
    ... has joined Microsoft Corp. in a,strategic relationship ... consumer health platform. In this relationship, ... Diet.com Weight Tracker, and Diet.com Blood,Glucose Tracker, ... will,enable users to share information with physicians, ...
    ... 4 AmeriCares and,International Medical Corps (IMC) are ... responding to the cholera outbreak in that country. ... diarrhea have spread,through northern Iraq recently, affecting some ... in Baghdad at the end of September.,According to ...
    ... Applications Lead to Texas Children,s ... ... developer of the,OnBase enterprise content management (ECM) software suite, has ... provider,for document management. (Logo: http://www.newscom.com/cgi-bin/prnh/20070110/CLW019LOGO ) ...
    ... people are bitten again by ticks , THURSDAY, Oct. 4 ... relapse of Lyme disease may actually have been bitten by ... new study suggests. , "It is striking how often re-infection ... of medicine at New York Medical College, said in a ...
    Cached Medicine News:Health News:FDA Announces Initiative to Bolster Generic Drug Program 2Health News:Canola Oil Can Help Americans Meet Dietary Fat Recommendations 2Health News:Diet.com Enters Strategic Collaboration To Support Microsoft HealthVault 2Health News:AmeriCares and International Medical Corps Airlift Relief for Cholera Outbreak In Iraq 2Health News:AmeriCares and International Medical Corps Airlift Relief for Cholera Outbreak In Iraq 3Health News:Texas Children's Hospital Selects Hyland Software's OnBase to Complete Electronic Medical Records Initiative 2Health News:Texas Children's Hospital Selects Hyland Software's OnBase to Complete Electronic Medical Records Initiative 3Health News:Lyme Disease Relapse Often a New Infection 2
    Grab one and go, One of the smallest handheld oximeters available, Datex-Ohmeda s TuffSat is the ideal spot-check solution for hospital, home care, transport, and EMS. TuffSat comes fully loaded wi...
    The GEM OPL CO-Oximeter provides comprehensive oxygenation status in an easy-to-use, portable manner. The GEM OPL is the ideal solution for laboratory or point-of-care CO-Oximetry testing....
    Maxi-Therm® hyper-hypothermia water blankets from Cincinnati Sub-Zero are designed for single-patient use. These blankets are easy to clean, stain resistant and ideal for isolation cases....
    ... blankets are the most durable out of ... is formed with durable urethane. These blankets ... that of most competitive plastic blankets. Blood, ... surface. Set-up is also simplified through the ...
    Medicine Products: